{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T19:26:22Z","timestamp":1777663582323,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Adding clomiphene citrate (CC) and\/or letrozole (LE) to in vitro fertilization (IVF) cycles for mild ovarian stimulation is a general approach. Although lots of researches have demonstrated partial benefits of the strategy, all-around effects of oral medications remained deficient. This paper aims to assess whether an addition of oral medication will result in considerable outcomes on T-Gn (total dose of gonadotropin), Gn days, total retrieved ova, high quality embryos, blastocyst number, ovarian hyperstimulation syndrome (OHSS) rate, clinical pregnancy rate and cumulative pregnancy rate, even if it was not conventional mild\/minimal stimulations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Participants were categorized to three diverse populations as high responders, normal responders and poor responders according to basal antral follicle count. T-Gn in patients treated with CC\/LE distinctly decreased from 2496.96\u2009IU\/d to 1827.68\u2009IU\/d, from 2860.28\u2009IU\/d to 2119.99\u2009IU\/d, and from 3182.15\u2009IU\/d to 1802.84\u2009IU\/d, respectively. For high ovary responders and normal responders, the OHSS incidence rate also declined from 29.2 to 4.3% (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and from 1.1 to 0.0% (<jats:italic>P<\/jats:italic>\u2009=\u20090.090). Other, there was no statistical difference with respect to the T-retrieved ova (total retrieved ova), high quality embryos, cultured blastocyst and blastocyst number in high responders. For normal responders and poor ovary responders, T-Gn, Gn days, T-retrieved ova, high quality embryos, cultured blastocyst and blastocysts number in oral medications group all apparently decreased. Clinical pregnancy rate per fresh cycle of poor responders with prior oral medications was significantly decreased (25.7% vs. 50.8%, <jats:italic>P<\/jats:italic>\u00a0=\u20090.005), and no significant differences in high responders and normal responders were expressed (52.5% vs. 44.2%, <jats:italic>P<\/jats:italic>\u00a0=\u20090.310; 51.9% vs. 42.4%, <jats:italic>P<\/jats:italic>\u00a0=\u20090.163) between two groups of participants. The numbers of cumulative pregnancy rates were lower in the conventional group compared to the add group for high (75.90% versus 81.03%, <jats:italic>P<\/jats:italic>\u00a0=\u20090.279), normal (62.69% versus 71.36%, <jats:italic>P<\/jats:italic>\u00a0=\u20090.016) and poor (39.74% versus 68.21%, <jats:italic>P<\/jats:italic>\u00a0&lt;\u20090.001) responders.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The addition of CC\/LE to the ovulation induction during IVF has certain efficacy in terms of low cost, low OHSS incidence. CC\/LE deserves more recommendations as a responsible strategy in high responders due to advantageous pregnancy outcomes. For normal responders, the strategy needs to be considered with more comprehensive factors.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-021-03668-x","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T22:02:45Z","timestamp":1617314565000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Does the additional use of clomiphene citrate or letrozole for in vitro fertilization deserve more attention?"],"prefix":"10.1186","volume":"21","author":[{"given":"Ying","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Hua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Ling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng-Li","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Qian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"issue":"Suppl 2","key":"3668_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S1472-6483(10)60271-4","volume":"19","author":"D Huisman","year":"2009","unstructured":"Huisman D, Raymakers X, Hoomans EH. Understanding the burden of ovarian stimulation: fertility expert and patient perceptions. Reprod BioMed Online. 2009;19(Suppl 2):5\u201310.","journal-title":"Reprod BioMed Online"},{"issue":"2","key":"3668_CR2","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.fertnstert.2003.06.029","volume":"81","author":"C Olivius","year":"2004","unstructured":"Olivius C, Friden B, Borg G, Bergh C. Why do couples discontinue in vitro fertilization treatment? A cohort study. Fertil Steril. 2004;81(2):258\u201361.","journal-title":"Fertil Steril"},{"issue":"3","key":"3668_CR3","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0015-0282(16)48069-6","volume":"42","author":"EY Adashi","year":"1984","unstructured":"Adashi EY. Clomiphene citrate: mechanism(s) and site(s) of action--a hypothesis revisited. Fertil Steril. 1984;42(3):331\u201344.","journal-title":"Fertil Steril"},{"issue":"9","key":"3668_CR4","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1093\/humrep\/14.9.2328","volume":"14","author":"K Vendola","year":"1999","unstructured":"Vendola K, Zhou J, Wang J, Bondy CA. Androgens promote insulin-like growth factor-I and insulin-like growth factor-I receptor gene expression in the primate ovary. Hum Reprod. 1999;14(9):2328\u201332.","journal-title":"Hum Reprod"},{"issue":"4","key":"3668_CR5","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.rbmo.2020.05.010","volume":"41","author":"G Nargund","year":"2020","unstructured":"Nargund G, Fauser B. Mild ovarian stimulation for IVF is the smartest way forward. Reprod BioMed Online. 2020;41(4):569\u201371.","journal-title":"Reprod BioMed Online"},{"issue":"11","key":"3668_CR6","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1093\/humrep\/dem285","volume":"22","author":"G Nargund","year":"2007","unstructured":"Nargund G, Fauser BC, Macklon NS, Ombelet W, Nygren K, Frydman R. Rotterdam ICGoTfOSfIVF: the ISMAAR proposal on terminology for ovarian stimulation for IVF. Hum Reprod. 2007;22(11):2801\u20134.","journal-title":"Hum Reprod"},{"issue":"11","key":"3668_CR7","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1093\/humrep\/dep343","volume":"24","author":"F Zegers-Hochschild","year":"2009","unstructured":"Zegers-Hochschild F, Adamson GD, de Mouzon J, Ishihara O, Mansour R, Nygren K, Sullivan E, van der Poel S, International Committee for Monitoring Assisted Reproductive T, World Health O. The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary on ART terminology, 2009. Hum Reprod. 2009;24(11):2683\u20137.","journal-title":"Hum Reprod"},{"issue":"4","key":"3668_CR8","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.rbmo.2011.12.011","volume":"24","author":"N Gleicher","year":"2012","unstructured":"Gleicher N, Weghofer A, Barad DH. A case-control pilot study of low-intensity IVF in good-prognosis patients. Reprod BioMed Online. 2012;24(4):396\u2013402.","journal-title":"Reprod BioMed Online"},{"issue":"4","key":"3668_CR9","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s00404-009-1252-4","volume":"281","author":"MA Karimzadeh","year":"2010","unstructured":"Karimzadeh MA, Ahmadi S, Oskouian H, Rahmani E. Comparison of mild stimulation and conventional stimulation in ART outcome. Arch Gynecol Obstet. 2010;281(4):741\u20136.","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"3668_CR10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.fertnstert.2015.05.006","volume":"104","author":"AP Ferraretti","year":"2015","unstructured":"Ferraretti AP, Gianaroli L, Magli MC, Devroey P. Mild ovarian stimulation with clomiphene citrate launch is a realistic option for in vitro fertilization. Fertil Steril. 2015;104(2):333\u20138.","journal-title":"Fertil Steril"},{"key":"3668_CR11","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/humupd\/dmaa035","volume":"27","author":"AK Datta","year":"2020","unstructured":"Datta AK, Maheshwari A, Felix N, Campbell S, Nargund G. Mild versus conventional ovarian stimulation for IVF in poor, normal and hyper-responders: a systematic review and meta-analysis. Hum Reprod Update. 2020;27:229\u201353.","journal-title":"Hum Reprod Update"},{"issue":"8","key":"3668_CR12","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1093\/humrep\/17.8.2022","volume":"17","author":"JB Engel","year":"2002","unstructured":"Engel JB, Ludwig M, Felberbaum R, Albano C, Devroey P, Diedrich K. Use of cetrorelix in combination with clomiphene citrate and gonadotrophins: a suitable approach to 'friendly IVF'? Hum Reprod. 2002;17(8):2022\u20136.","journal-title":"Hum Reprod"},{"issue":"1","key":"3668_CR13","first-page":"55","volume":"1","author":"A Trounson","year":"1982","unstructured":"Trounson A. Current perspectives of in vitro fertilization and embryo transfer. Clin Reprod Fertil. 1982;1(1):55\u201365.","journal-title":"Clin Reprod Fertil"},{"issue":"8","key":"3668_CR14","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1080\/09513590.2018.1435636","volume":"34","author":"B Jin","year":"2018","unstructured":"Jin B, Niu Z, Xu B, Chen Q, Zhang A. Comparison of clinical outcomes among dual ovarian stimulation, mild stimulation and luteal phase stimulation protocols in women with poor ovarian response. Gynecol Endocrinol. 2018;34(8):694\u20137.","journal-title":"Gynecol Endocrinol"},{"issue":"11","key":"3668_CR15","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1007\/s10815-011-9643-4","volume":"28","author":"VP Jovanovic","year":"2011","unstructured":"Jovanovic VP, Kort DH, Guarnaccia MM, Sauer MV, Lobo RA. Does the addition of clomiphene citrate or letrazole to gonadotropin treatment enhance the oocyte yield in poor responders undergoing IVF? J Assist Reprod Genet. 2011;28(11):1067\u201372.","journal-title":"J Assist Reprod Genet"},{"issue":"2","key":"3668_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3109\/01443615.2014.940290","volume":"35","author":"A Oride","year":"2015","unstructured":"Oride A, Kanasaki H, Miyazaki K. Comparison of human menopausal gonadotropin stimulation with and without clomiphene for in-vitro fertilisation in poor-responders. J Obstet Gynaecol. 2015;35(2):163\u20137.","journal-title":"J Obstet Gynaecol"},{"issue":"5 Suppl 1","key":"3668_CR17","first-page":"S187","volume":"86","author":"Practice Committee of the American Society for Reproductive M","year":"2006","unstructured":"Practice Committee of the American Society for Reproductive M. Use of clomiphene citrate in women. Fertil Steril. 2006;86(5 Suppl 1):S187\u201393.","journal-title":"Fertil Steril"},{"issue":"7","key":"3668_CR18","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s10815-014-0227-y","volume":"31","author":"A Revelli","year":"2014","unstructured":"Revelli A, Chiado A, Dalmasso P, Stabile V, Evangelista F, Basso G, Benedetto C. \u201cMild\u201d vs. \u201clong\u201d protocol for controlled ovarian hyperstimulation in patients with expected poor ovarian responsiveness undergoing in vitro fertilization (IVF): a large prospective randomized trial. J Assist Reprod Genet. 2014;31(7):809\u201315.","journal-title":"J Assist Reprod Genet"},{"issue":"6","key":"3668_CR19","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1111\/jog.13624","volume":"44","author":"R Satwik","year":"2018","unstructured":"Satwik R, Kochhar M. Effect of simultaneously started clomiphene citrate and gonadotropins in antagonist regimes, on cumulative live births, fresh-cycle live births and cost of stimulation in IVF cycles. J Obstet Gynaecol Res. 2018;44(6):1107\u201317.","journal-title":"J Obstet Gynaecol Res"},{"issue":"2","key":"3668_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.21873\/invivo.11050","volume":"31","author":"C Siristatidis","year":"2017","unstructured":"Siristatidis C, Salamalekis G, Dafopoulos K, Basios G, Vogiatzi P, Papantoniou N. Mild versus conventional ovarian stimulation for poor responders undergoing IVF\/ICSI. In Vivo. 2017;31(2):231\u20137.","journal-title":"In Vivo"},{"issue":"7","key":"3668_CR21","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/humrep\/der092","volume":"26","author":"AP Ferraretti","year":"2011","unstructured":"Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L. Definition EwgoPOR: ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26(7):1616\u201324.","journal-title":"Hum Reprod"},{"issue":"1","key":"3668_CR22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S1472-6483(10)60042-9","volume":"19","author":"A Golan","year":"2009","unstructured":"Golan A, Weissman A. Symposium: update on prediction and management of OHSS. A modern classification of OHSS. Reprod BioMed Online. 2009;19(1):28\u201332.","journal-title":"Reprod BioMed Online"},{"issue":"12","key":"3668_CR23","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1093\/oxfordjournals.humrep.a137993","volume":"8","author":"A Dokras","year":"1993","unstructured":"Dokras A, Sargent IL, Barlow DH. Human blastocyst grading: an indicator of developmental potential? Hum Reprod. 1993;8(12):2119\u201327.","journal-title":"Hum Reprod"},{"issue":"9","key":"3668_CR24","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1093\/humrep\/dex234","volume":"32","author":"F Zegers-Hochschild","year":"2017","unstructured":"Zegers-Hochschild F, Adamson GD, Dyer S, Racowsky C, de Mouzon J, Sokol R, Rienzi L, Sunde A, Schmidt L, Cooke ID, et al. The international glossary on infertility and fertility care, 2017. Hum Reprod. 2017;32(9):1786\u2013801.","journal-title":"Hum Reprod"},{"issue":"2","key":"3668_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10815-014-0387-9","volume":"32","author":"S Fernandez-Shaw","year":"2015","unstructured":"Fernandez-Shaw S, Cercas R, Brana C, Villas C, Pons I. Ongoing and cumulative pregnancy rate after cleavage-stage versus blastocyst-stage embryo transfer using vitrification for cryopreservation: impact of age on the results. J Assist Reprod Genet. 2015;32(2):177\u201384.","journal-title":"J Assist Reprod Genet"},{"issue":"1","key":"3668_CR26","first-page":"112","volume":"32","author":"MA Youssef","year":"2017","unstructured":"Youssef MA, van Wely M, Al-Inany H, Madani T, Jahangiri N, Khodabakhshi S, Alhalabi M, Akhondi M, Ansaripour S, Tokhmechy R, et al. A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized non-inferiority trial. Hum Reprod. 2017;32(1):112\u20138.","journal-title":"Hum Reprod"},{"issue":"6","key":"3668_CR27","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.fertnstert.2018.03.019","volume":"109","author":"Practice Committee of the American Society for Reproductive Medicine","year":"2018","unstructured":"Practice Committee of the American Society for Reproductive Medicine. Electronic address Aao: comparison of pregnancy rates for poor responders using IVF with mild ovarian stimulation versus conventional IVF: a guideline. Fertil Steril. 2018;109(6):993\u20139.","journal-title":"Fertil Steril"},{"key":"3668_CR28","first-page":"CD008528","volume":"11","author":"MS Kamath","year":"2017","unstructured":"Kamath MS, Maheshwari A, Bhattacharya S, Lor KY, Gibreel A. Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation. Cochrane Database Syst Rev. 2017;11:CD008528.","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"3668_CR29","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1093\/humrep\/deh359","volume":"19","author":"SK Goswami","year":"2004","unstructured":"Goswami SK, Das T, Chattopadhyay R, Sawhney V, Kumar J, Chaudhury K, Chakravarty BN, Kabir SN. A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report. Hum Reprod. 2004;19(9):2031\u20135.","journal-title":"Hum Reprod"},{"issue":"7","key":"3668_CR30","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1080\/09513590.2017.1296128","volume":"33","author":"C Siristatidis","year":"2017","unstructured":"Siristatidis C, Dafopoulos K, Vrantza T, Salamalekis G, Basios G, Vogiatzi P, Pergialiotis V, Papantoniou N. Mild versus conventional antagonist ovarian stimulation protocols in expected normal responders undergoing IVF\/ICSI: a case-control study. Gynecol Endocrinol. 2017;33(7):553\u20136.","journal-title":"Gynecol Endocrinol"},{"issue":"6","key":"3668_CR31","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1080\/09513590.2017.1416464","volume":"34","author":"I Sanverdi","year":"2018","unstructured":"Sanverdi I, Kutlu HT, Bilgic BE, Incebiyik A. A comparison of treatment results of the different treatment protocols in patients with poor ovarian response. Gynecol Endocrinol. 2018;34(6):524\u20137.","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"3668_CR32","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3109\/09513590.2015.1110133","volume":"32","author":"T Ecemis","year":"2016","unstructured":"Ecemis T, Tasci Y, Caglar GS. Controlled ovarian hyperstimulation with sequential letrozole co-treatment in normo\/high responders. Gynecol Endocrinol. 2016;32(3):206\u20139.","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"3668_CR33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12958-019-0483-x","volume":"17","author":"X Yang","year":"2019","unstructured":"Yang X, Lin G, Lu G, Gong F. Letrozole supplementation during controlled ovarian stimulation in expected high responders: a pilot randomized controlled study. Reprod Biol Endocrinol. 2019;17(1):43.","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"3668_CR34","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12958-018-0405-3","volume":"16","author":"G D'Amato","year":"2018","unstructured":"D'Amato G, Caringella AM, Stanziano A, Cantatore C, Palini S, Caroppo E. Mild ovarian stimulation with letrozole plus fixed dose human menopausal gonadotropin prior to IVF\/ICSI for infertile non-obese women with polycystic ovarian syndrome being pre-treated with metformin: a pilot study. Reprod Biol Endocrinol. 2018;16(1):89.","journal-title":"Reprod Biol Endocrinol"},{"issue":"4","key":"3668_CR35","first-page":"257","volume":"13","author":"MA Gadalla","year":"2020","unstructured":"Gadalla MA, Norman RJ, Tay CT, Hiam DS, Melder A, Pundir J, Thangaratinam S, Teede HJ, Mol BWJ, Moran LJ. Medical and surgical treatment of reproductive outcomes in polycystic ovary syndrome: an overview of systematic reviews. Int J Fertil Steril. 2020;13(4):257\u201370.","journal-title":"Int J Fertil Steril"},{"issue":"6","key":"3668_CR36","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/humupd\/dmw025","volume":"22","author":"AH Balen","year":"2016","unstructured":"Balen AH, Morley LC, Misso M, Franks S, Legro RS, Wijeyaratne CN, Stener-Victorin E, Fauser BC, Norman RJ, Teede H. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update. 2016;22(6):687\u2013708.","journal-title":"Hum Reprod Update"},{"key":"3668_CR37","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.2147\/DDDT.S134671","volume":"11","author":"M Hajishafiha","year":"2017","unstructured":"Hajishafiha M, Dehghan M, Kiarang N. Erratum: Combined letrozole and clomiphene versus letrozole and clomiphene alone in infertile patients with polycystic ovary syndrome [Erratum]. Drug Design Dev Ther. 2017;11:1367.","journal-title":"Drug Design Dev Ther"},{"issue":"4","key":"3668_CR38","doi-asserted-by":"publisher","first-page":"185","DOI":"10.5603\/GP.a2020.0037","volume":"91","author":"S Ege","year":"2020","unstructured":"Ege S, Bademkiran MH, Peker N, Tahaoglu AE, Hancer Caca FN, Ozcelik SM. A comparison between a combination of letrozole and clomiphene citrate versus gonadotropins for ovulation induction in infertile patients with clomiphene citrateresistant polycystic ovary syndrome - a retrospective study. Ginekol Pol. 2020;91(4):185\u20138.","journal-title":"Ginekol Pol"},{"key":"3668_CR39","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ejogrb.2016.05.027","volume":"203","author":"E Bastu","year":"2016","unstructured":"Bastu E, Buyru F, Ozsurmeli M, Demiral I, Dogan M, Yeh J. A randomized, single-blind, prospective trial comparing three different gonadotropin doses with or without addition of letrozole during ovulation stimulation in patients with poor ovarian response. Eur J Obstet Gynecol Reprod Biol. 2016;203:30\u20134.","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-03668-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12884-021-03668-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-03668-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T22:04:01Z","timestamp":1617314641000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-021-03668-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3668"],"URL":"https:\/\/doi.org\/10.1186\/s12884-021-03668-x","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,1]]},"assertion":[{"value":"23 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were performed in accordance with Declaration of Helsinki. All procedures performed in the study involving human participants were approved by the ethics committee of Fourth Hospital of Shijiazhuang. We obtained informed consent from the patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"275"}}